Skip to main content
CBZCBIZ, Inc.Sell5.5·$35.26+3.89%
Open full analysis

CBIZ, Inc. (CBZ) Stock Analysis

Recovery setup

SellModerate Confidence

Industrials · Specialty Business Services

Sell if holding. Analyst target reached at $35.26 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.1): -0.5.

CBIZ provides professional services — accounting, tax, advisory, benefits, and insurance — to middle-market businesses across more than 140 locations in 23 major U.S. markets. In 2025, total revenue was $2.76 billion, with the Financial Services segment contributing 83.4%... Read more

$35.26-0.9% A.UpsideScore 5.5/10#3 of 21 Specialty Business Services
QualityF-score7 / 9FCF yield10.45%
Stop $32.79Target $34.96(resistance)A.R:R -0.1:1
Analyst target$41.00+16.3%4 analysts
$34.96our TP
$35.26price
$41.00mean
$45

Sell if holding. Analyst target reached at $35.26 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.1): -0.5. Chart setup: Death cross but MACD improving, RSI 64. Score 5.5/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 45d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About CBIZ, Inc.

About CBIZ, Inc.

CBIZ generated $2.76 billion in total revenue in 2025, with the Financial Services segment — accounting, tax, advisory, and technology — contributing $2.30 billion or 83.4% of total, up from 75.1% in 2024 following the Marcum non-attest acquisition. Benefits and Insurance Services contributed $409.6 million (14.9%) and National Practices $46.9 million (1.7%). The company employs more than 9,500 people across more than 140 locations in 23 major markets, with no unionized workforce disclosed.

CBIZ earns revenue through direct professional services fees and through Administrative Service Agreements (ASAs) with four independent CPA firms — principally CBIZ CPAs, P.C. (formerly Mayer Hoffman McCann, P.C., with 421 stockholders) — under which CBIZ provides staffing, office management, and administrative support in exchange for fees. ASA fees totaled approximately $651.2 million in 2025, up from $306.5 million in 2024, with the majority of revenues related to privately-held clients and governmental agencies. The Financial Services segment also includes government health care consulting through Myers and Stauffer LC, an independent national CPA firm with 43 equity members. The National Practices segment derives all revenue from a single client under a cost-plus contract expiring December 31, 2028. Core accounting and tax revenue is front-loaded — most annual EPS is earned in the first half of the year during tax season — while Benefits and Insurance Services revenue is more stable across quarters.

Show full overview

CBIZ faces a distinctive regulatory constraint: the SEC classifies the company as an associated entity of its ASA-linked CPA firms, prohibiting it from providing services to or holding interests in those firms' SEC-reporting attest clients. The Marcum integration significantly increased the number of CBIZ CPAs' SEC-reporting attest clients, and CBIZ CPAs is now subject to annual PCAOB inspection following prior PCAOB and SEC sanctions against Marcum for quality control failures. If independence conflicts cannot be managed, ASA fee revenue — approximately $651.2 million in 2025 — could be curtailed, making the continuation of ASA relationships a material operational dependency the 10-K explicitly identifies as a risk.

See also: Industrials · Specialty Business Services

From CBIZ, Inc.'s most recent 10-K filing, extracted June 9, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-14

Recent Developments — CBIZ, Inc.

Generated 2026-06-15T18:11:46Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 202645d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Analyst target reached - limited upside remaining
Leverage penalty (D/E 1.1): -0.5
Below 200-MA, MA slope -11.2%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)13.8
P/E (Fwd)7.8
Mkt Cap$1.9B
EV/EBITDA9.0
Profit Mgn5.6%
ROE8.1%
Rev Growth1.3%
Beta0.99
DividendNone
Rating analysts9

Quality Signals

Piotroski F7/9

Options Flow

P/C1.67bearish
IV93%elevated
Max Pain$35-0.7% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.0
Support Resistance
0.6
Bollinger
0.8

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
1.4
Quality Rank
4.6
Value Rank
8.1
Attractive P/E vs peers
GatesA.R:R -0.1=NEGATIVEDeath cross (50MA < 200MA)Momentum 6.6>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 45d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
64 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $28.25Resistance $35.67

Price Targets

$33
$35
A.Upside-0.9%
A.R:R-0.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-1.2% upside)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (45d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CBZ stock a buy right now?

Sell if holding. Analyst target reached at $35.26 — A.R:R is negative (-0.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 1.1): -0.5. Chart setup: Death cross but MACD improving, RSI 64. Prior stop was $32.79. Score 5.5/10, moderate confidence.

What is the CBZ stock price target?

Take-profit target: $34.96 (-0.9% upside). Prior stop was $32.79. Stop-loss: $32.79.

What are the risks of investing in CBZ?

Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.1): -0.5; Below 200-MA, MA slope -11.2%/30d (confirmed downtrend).

Is CBZ overvalued or undervalued?

CBIZ, Inc. trades at a P/E of 13.8 (forward 7.8). TrendMatrix value score: 8.0/10. Verdict: Sell.

What do analysts say about CBZ?

9 analysts cover CBZ with a consensus score of 3.9/5. Average price target: $41.

What does CBIZ, Inc. do?CBIZ provides professional services — accounting, tax, advisory, benefits, and insurance — to middle-market businesses...

CBIZ provides professional services — accounting, tax, advisory, benefits, and insurance — to middle-market businesses across more than 140 locations in 23 major U.S. markets. In 2025, total revenue was $2.76 billion, with the Financial Services segment contributing 83.4% following the Marcum non-attest business acquisition that closed in 2024. Benefits and Insurance Services contributed 14.9% and National Practices 1.7%, the latter serving a single client under a cost-plus contract.

Related stocks: GPN (Global Payments Inc.) · CMPR (Cimpress PLC) · TIC (TIC Solutions, Inc.) · RTO (Rentokil Initial plc) · DLB (Dolby Laboratories)
Home Stocks CBZ

Latest news

Latest News

Benzinga46d ago
Benzinga47d ago
Benzinga47d agoEarnings
Benzinga47d agoEarnings
Benzinga47d agoEarnings
Benzinga66d ago